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ABSTRACT
The HAM/TSP caused by HTLV-1 infection usually affects patients to disabling states, and 
sometimes can lead them to paraplegia presenting symptoms of depression and anxiety, im-
pacting on quality of life. Objective: The purpose of this study was to evaluate the frequency of 
depression and anxiety and its impact on quality of life in HTLV-1-infected TSP/HAM patients. 
Material and Methods: This was a cross-sectional study including 67 asymptomatic (control group) 
and 63 with TSP/HAM subjects. The instruments used were a demographic questionnaire, scales 
for anxiety and depression diagnosis (BDI and BAI), questionnaire for the assessment of Quality 
of Life of the World Health Organization (WHOQOL-Brief) and neurological scale to measure the 
disability level (Osame’s Disability Status Scale). All patients had HTLV-I diagnosis by serological 
and molecular approaches, monitored at Instituto de Infectologia Emílio Ribas from May 2008 to 
July 2009. Data were analyzed statistically by frequencies, the Mann-Whitney test and the Spearman 
correlation test. Data among groups were analyzed and correlated with functional and severity as-
pects. Results: The results showed that patients with HAM/TSP compared to asymptomatic carriers 
had higher rates of depression (p < 0.001) and anxiety (p < 0.001), and impairment on quality of 
life in the areas of: dissatisfaction with health (p < 0.001), physical (p < 0.001) and the environment 
(p = 0.003). The main factors that correlated with levels of depression and anxiety and the domains of 
the WHOQOL-brief were: education, family income and social class. Conclusion: A well conducted 
evaluation and counseling may help in treatment, for a better quality of life of these patients.
Keywords: anxiety; depression; quality of life; human T-lymphotropic virus 1.
INTRODUCTION
Human T-cell lymphotrophic virus type 1 
(HTLV-1), first isolated in 1980, has been etio-
logically associated with a neurologic syndrome 
called HTLV-1 associated myelopathy/tropical 
spastic paraparesis (HAM/TSP) as well as with 
adult T-cell leukemia/lymphoma (ATLL) and 
with other clinical manifestations, such as uvei-
tis, arthritis, infective dermatitis and polymy-
ositis.1-4 HTLV-1 infection is endemic in Brazil 
and, an estimation by the Ministry of Health5 
states that 750,000 people are carriers of HTLV, 
with a prevalence varying from 0.4% to 18% 
depending on the geographic region.6-10
Psychiatric disorders appear to be common 
in patients with chronic diseases, as in tropical 
spastic paraparesis/HTLV-1 associated myelopa-
thy (HAM/TSP). Besides, depression and anxiety 
symptoms may contribute to progressive dis-
ability and limitations in daily living activities im-
pacting their perceptions about quality of life.11-13
The association between HTLV and de-
pression has not been extensively studied so 
far. Stumpf et al.12 reported the presence of 
depressive symptoms in individuals infected 
with HTLV-1, followed in open prevalent co-
hort study of seropositive blood donors in a 
blood center in Minas Gerais. Preliminary re-
sults of a recent study in the cohort suggested 
greater prevalence of depression among carri-
ers of HTLV-1 compared to seronegative blood 
donors (45.5% versus 18.8%, p = 0.0543).
Souza13 conducted a study of 36 patients 
infected with HTLV-1, which showed the 
presence of depressive symptoms in 10 (28%) 
patients, 20% with tropical spastic parapare-
sis and 8% asymptomatic. The author notes 
that 77% of patients interviewed had, at least, 
one symptom of depression. The most frequent 
symptoms were: sleep disturbance, lack of 
appetite, and anhedonia. Another study con-
ducted by Carvalho et al.14 with 50 patients 
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with HTLV-1 (26 were symptomatic and 24 asymptomatic) 
observed that 21 (42%) had psychiatric comorbidity, 17 
(34%) presented mood change, and 11 (22%) anxiety.
Regarding the studies on quality of life, Shublaq,15 in 
his MSc dissertation, assessed the functional capacity and 
quality of life in 30 patients with myelopathy associated with 
HTLV-1, and concluded that the progression of the deficit 
compromises functional independence in daily activities. 
Most participants were described as being dependent on 
external care, and the impact of this dependence was dem-
onstrated by the measurement of quality of life.
In the study conducted by Coutinho et al.16 with 57 
patients with HAM/TSP, it was observed that the physical 
aspect is the factor that most affects the quality of life of 
these patients, and that the impairment in daily activities is 
directly related to the ability to mobility and locomotion.
The purpose of this study was to assess the frequency 
of depression, anxiety and quality of life in TSP/HAM and 
asymptomatic HTLV-1 infected patients, in relation to soci-
odemographic and clinical features.
MATERIAL AND METHODS 
We conducted a cross-sectional study with 130 patients: 
63 with HAM/TSP and 67 asymptomatic HTLV-1 control 
group; a demographic questionnaire, scales for anxiety and 
depression diagnosis (BDI and BAI),17,18 questionnaire for 
assessing Quality of Life of the World Health Organization 
(WHOQOL-Brief),19 and neurological scale to measure the 
disability level (Osame’s Disability Status Scale)4 were used 
as instruments. All patients had HTLV-1 diagnosed by se-
rological and molecular approaches conducted at Instituto 
de Infectologia Emílio Ribas from May 2008 to July 2009. 
Data were analyzed by frequencies, Mann-Whitney test and 
the Spearman correlation test, which were considered sig-
nificant when p < 0.05.20
RESULTS
Ninety-three patients (71.5%) were female and 37 (28.4%) 
male, with a mean age of 49.8 years (SD = 11.6 years). 
Most participants were white (39.2%), married (32.3%), 
on social class C (54.6%), with a family income of one 
to five minimum wages (79.2%) and had an educational 
level of 0-4 years (34.6%), manual workers (30%), and co-
infections: HTLV-1/HCV (7.2%), HTLV-1/HIV (7.2%), 
HTLV-1/HIV/HCV (4.8%), HTLV-1/HBV (0.8%) and 
HTLV-1/HIV/HBV (0.8%).
In Osame’s scale, 21 patients had partial incapacity to 
walk without any help; 31 patients had partial incapacity 
to walk needing hand support; and 11 patients had inca-
pacity to walk.
The frequency of moderate/severe depression was 
40.3%/19% (59.3%) in the HAM/TSP group and 13.5%/8.9% 
(22.4%) in the control group (Table 1). The most prevalent 
symptoms were fatigue (74.6%), health concern (73.8%), 
irritability (65.3%), sleep disturbance (63.8%), difficulty to 
work (61.5 %), reduction/lack of sexual desire (57.6%), apa-
thy (54.7%), self-criticism (53.8%) and anhedonia (53%).
The presence/absence of HAM/TSP is significantly associ-
ated with high level depression (p < 0.001). Other signifi-
cantly associated factors were: educational level (p < 0.001), 
family income (p = 0.002), social class (p < 0.001). In the 
group of symptomatic patients, also showed significance: 
beginning of clinical symptoms (p = 0.050, p = 0.248), se-
rological tests for the family (p = 0.002), kinship (children) 
(p < 0.001, p = -0.449) and kinship (children) with positive 
results (p = 0.005). In the asymptomatic group, the variables 
significantly associated were: missing doctor appointments 
(p = 0.040), time off from the clinic (p = 0.035), absence of 
family/social support (p < 0.015), coinfection (p = 0.03).
The frequency of moderate/severe anxiety was 
31.7%/23.8% (55.5%) in the HAM/TSP group and 
14.9%/10.4% (25.3%) in the control group (Table 2). The 
most prevalent symptoms were nervousness (63.8%), numb-
ness or tingling (59.2%), difficulty to relax (56.2%), lack of 
balance (55.4%) and fear of losing control (52.3%).
Statistical analysis by Mann-Whitney U test was in 
1,217 (z = 4.297) with a probability p < 0.001, which shows 
that presence/absence of HAM/TSP was associated with 
high level anxiety. Other significantly associated factors 
were: sex (p = 0.012), family income (p = 0.003), residence 
place (p = 0.040), social class (p = 0.003), onset of clinical 
Table 1. Frequency and intensity of depression in 130 patients attended at the Instituto de Infectologia Emílio 
Ribas from May to July 2009 
High level depression (BDI) All patients (n = 130) Symptomatic (n = 63) Asymptomatic (n = 67)
Minimum 59 (45.4%) 18 (28.5%) 41 (61.1%)
Slight 19 (14.6%) 8 (12.6%) 11 (16.4%)
Moderate 34 (26.2%) 25 (40.3%) 9 (13.5%)
Severe 18 (13.8%) 12 (19%) 6 (8.9%)
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Table 2. Frequency and intensity of anxiety in 130 patients attended at the Instituto de Infectologia Emílio 
Ribas from May 2008 to July 2009 
High level anxiety (BAI) All patients (n = 130) Symptomatic (n = 63) Asymptomatic (n = 67)
Minimum 58 (44.6%) 15 (23.8%) 43 (64.1%)
Slight 20 (15.4%) 13 (20.6%) 7 (10.4%)
Moderate 30 (23.1%) 20 (31.7%) 10 (14.9%)
Severe 22 (17%) 15 (23.8%) 7 (10.4%)
Table 3. Distribution of domains according to quality of life questionnaire (WHOQOL-Brief) among  
63 symptomatic patients with infection by HTLV-1 treated at Instituto de Infectologia Emílio Ribas
 Quality of life Health Physical Psychological Social Environment 
   domain domain relationships
Very satisfied 2 (3.2%) 13 (20.6%) 1 (1.6%) 0 2 (3.2%) 0
Dissatisfied 9 (14.2%) 28 (44.4%) 18 (18.5%) 11 (17.6%) 7 (11.2%) 19 (30.4%)
Neither satisfied/ 
22 (34.9%) 12 (19.2%) 30 (47.6%) 19 (30.4%) 18 (28.8%) 28 (42%)
 
nor dissatisfied
Satisfied 26 (41.3%) 10 (15.8%) 13 (20.6%) 25 (40%) 32 (51.2%) 23 (36.8%)
Very satisfied 4 (6.4%) 1 (1.5%) 1 (1.6%) 8 (12.8%) 5 (8%) 0
Table 4. Distribution of domains according to quality of life questionnaire (WHOQOL-Brief) among  
67 asymptomatic patients with infection by HTLV-1 treated at Instituto de Infectologia Emílio Ribas
 Quality of life Health Physical Psychological Social Environment 
   domain domain relationships
Very satisfied 1 (1.5%) 4 (5.9%) 0 0 0 0
Dissatisfied 3 (4.5%) 14 (24.3%) 5 (7.4%) 7 (10.5) 6 (9.0%) 4 (6%)
Neither satisfied/ 
17 (25.4%) 15 (24.3%) 11 (16.4%) 12 (18%) 14 (21%) 23 (34.5%)
 
nor dissatisfied
Satisfied 34 (50.8%) 27 (40.2%) 39 (58.2%) 32 (48%) 38 (57%) 36 (54%)
Very satisfied 12 (18%) 6 (8.9%) 13 (19.5%) 16 (24%) 9 (13.5%) 4 (6%)
symptoms (p < 0.001), missing doctor appointments 
(p = 0.040) and depression (p < 0.001). The group of symp-
tomatic patients also showed significance for: serological 
tests on relatives (p = 0.021), kinship (children) (p = 0.014) 
and depression (p < 0.001). In the asymptomatic group 
the variables significantly associated were: family income 
(p = 0.017), social class (p = 0.015) missing doctor ap-
pointment (p = 0.006), time off from the clinic (p = 0.048), 
coinfection (p = 0.046) and depression (p < 0.001).
Regarding quality of life, it was observed that pa-
tients with HAM/TSP had scores related mainly to 
satisfaction with health and physical environment. Pa-
tients with HAM/TSP reported almost three times more 
dissatisfaction with health (65%) than asymptomatic 
patients (26.7%), and in the physical domain 20.1% and 
7.4%, respectively. In the environment domain, the fre-
quency of dissatisfaction among patients with HAM/TSP 
was five times higher (30.4%) when compared to the group 
of asymptomatic patients (Tables 3 and 4).
The variables that associated satisfaction with the 
health field in the symptomatic group were: time of 
illness (p = 0.017), serologic testing by relatives (p = 0.002), 
Depression and quality of life
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kinship (p = 0.001), seropositivity (p = 0.001), depression 
(p = 0.001) and anxiety (p < 0.001). In the asymptomatic 
group the variables were housing (p = 0.005), coinfection 
(p = 0.029), depression (p < 0.001), and anxiety (p < 0.001).
In the physical domain, the variables associated with the 
outcome among symptomatic patients were: educational 
level (p = 0.012), family income (p = 0.050), social class 
(p = 0.041), duration of treatment (p = 0.041), relationship 
(children) (p = 0.002), serologic test results (p = (0.016). 
Among the asymptomatic patients, the following variables 
were significantly correlated: educational level (p = 0.008), 
family income (p = 0.001), housing (p = 0.028), social 
class (p < 0.001), family/social support (p = 0.004), depression 
(p < 0.001), and anxiety (p < 0.001).
In relation to the environment field, the variables that 
influenced the perception the groups with HAM/TSP were: 
education level (p = 0.034), family income (p = 0.002), so-
cial class (p = 0.018), family support (p = 0.033), depression 
(p = 0.010), transmission for mother (p = 0.001), kinship 
(children) (p < 0.001), kinship (children) with positive 
results (p = 0.010) in group symptomatic patients. Among 
the asymptomatic patients, the following variables were sig-
nificantly correlated: educational level (p = 0.001), family 
income (p = 0.004), social class (p = 0.010), family support 
(p = 0.031), depression (p < 0.001) and anxiety (p < 0.001), 
and doctor appointments (p = 0.028).
DISCUSSION
Level of schooling expresses differences between people, 
also in terms of access to information, with important de-
terminants on health. According to the report on the causes 
of social health inequities in Brazil (2008),21 access to in-
formation as a social determinant of health is not always 
recognized, being a mean of obtaining goods (tangible or 
intellectual) and growing professionally and personally.
The level of education, family income, social class, hous-
ing and social support can be identified as the central force 
that determines the socioeconomic impact of disease on 
daily life of a person. In accordance with the report on the 
causes of social health inequities in Brazil (2008),21 socio-
economic, cultural and environmental impacts of a given 
society, generate a social-economic stratification of indi-
viduals and group of people, giving them distinct social 
positions which, in turn, cause health differentials. In other 
words, the distribution of health and illness is not random, 
being associated with social status which, in turn, sets the 
conditions for life and work of individuals and groups.
Low level of education is an important factor in regard 
to occupation, as it leads to a higher probability of the in-
dividual developing work activities that require greater 
physical wear and using the body as the main work tool, 
with lower financial compensation. When hit by a chron-
ic illness that prevents the individual from using the full 
potential of the body, feelings of frustration, limitation, low 
self-esteem and dependency appear. The unfavorable per-
ception of the physical domain and social and financial 
factors such as unemployment, retirement, and work ab-
senteeism results in a poor perception of their quality of 
life and mood. On the asymptomatic HTLV-1 patients 
there were a negative perception about the quality of 
life and a fear of becoming carriers of HAM/TSP symp- 
toms and being unable to exercise their profession, 
which explains the correlation between educational 
level and high level of depression and physical domain.
Another variable of great relevance in the management 
of patients with HAM/TSP is the family/social support 
regarding physical and emotional dependence that these 
patients lay in the disease process and for maintaining life, 
being a determinant factor for stroke disease and the per-
ception of quality of life. The results indicated that the con-
trol group showed a significant correlation with the physi-
cal domain, social relationships and environment, and the 
latter two areas also with the group of HAM/TSP. There is 
a concern among asymptomatic patients whether the sup-
port of their physical domain is jeopardized by the out-
come of the infection. 
In this study we observed that coinfection presented 
itself as a significant variable within the control group 
when related to the degree of depression, anxiety, satisfac-
tion with health, physical dominance and social relations. 
Infection with HIV or HCV make the subject vulnerable 
and calls into question the fantasy of being less immune 
to the effects of time and death; therefore, possibly suf-
fering from diseases caused by these viruses. The illu-
sion of self-sufficiency and immortality is intermittently 
confronted by a real threat (much more real than the less 
than 5% possibility of having HAM/TSP). This threat is 
inner the subject, having nowhere to escape from it and 
may lead to suffering from social discrimination, multi-
ple loss (healthy body, relationship, occupation, leisure, 
etc.) and often the need to live a double life not be dis-
criminated.
CONCLUSION
Based on the results presented on this study we conclude 
that patients with HAM/TSP have higher levels of depres-
sion and anxiety, as well as greater impairment in quality 
of life than patients in the control group (asymptomatic), 
particularly in following areas: dissatisfaction with health, 
physical, environment.
The highest levels of depression and anxiety as well as 
the worst scores of quality of life and knowledge about the 
virus correlated with poor education, low family income 
and social class. The impact is determined by perception 
of the restriction and inability to perform activities that 
are essential for humans, as in the case of subjects of this 
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research with fewer financial, professional and intellectual 
resources, and not due to the physical disability arising 
from changes in HAM/TSP.
One of the ways suggested in order to reducing health in-
equities and quality of life is the adoption of public policies 
aimed at patients with HTLV that should consist of three 
parts: physical and mental health, socio-economic and edu-
cational care.
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